gritt.io›Find investors›Pharmaceutical in United States

Top 2026 Pharmaceutical Early Stage Investors in United States

Discover the top 849 pharmaceutical early stage investors in United States based on their portfolio. Get their email and LinkedIn info, or an intro.

849
Investors
539
With email
63%
Email rate
Oct 2026
Last updated

Investor search results

863 investors found
🌍 United States📊 early stage🏷 Pharmaceutical
Will Griffith
Will Griffith
Partner at ICONIQ
Mid stage181 investments 📍 United States
181
investments
Edward Lando
Edward Lando
Making things real
Early stage138 investments 📍 United States
138
investments
Tess Hau
Tess Hau
Venture Capitalist | Founder | LP | Investor | Frontier Tech | Robotics |Web3 | Artificial Intelligence | Gaming| | DeFi | Advisor | Mentor Capitalist | Global Speaker
Early stage98 investments 📍 United States
98
investments
Tom V.
Tom V.
Founder-Principal at Esalen Ventures, guiding startups to success in venture capital.
Mid stage87 investments 📍 United States
87
investments
Alexander Tran
Alexander Tran
Principal of Growth and Strategy at Penguin AI.
Early stage85 investments 📍 United States
85
investments
Klaus von Sayn-Wittgenstein
Klaus von Sayn-Wittgenstein
Investing in YC start ups
Early stage77 investments 📍 United States
77
investments
Mohamed (Sid) Siddeek
Mohamed (Sid) Siddeek
Corporate Vice President and Head of NVentures, NVIDIA’s Venture Capital Group
Late stage76 investments 📍 United States
76
investments
Caroline Farah Lembck, MBA, PhD (abd)
Caroline Farah Lembck, MBA, PhD (abd)
American Businesswoman, Investor & Entrepreneur Founder of LemVega Capital®, Puerto Rico’s leading investment firm going global | Featured NasDaq, Forbes | BA at 19 years old | MBA at 20 | PhD started at 20 | CEO at 21
Late stage76 investments 📍 United States
76
investments
Craig Cummings
Craig Cummings
General Partner at Moonshots Capital, Entrepreneur, Military Veteran
Early stage75 investments 📍 United States
75
investments
Helen Liang, PhD
Helen Liang, PhD
Founder & Managing Partner of FoundersX Ventures. Board Director. Featured on WSJ and Business Insider. Invited Speaker at TechCrunch. Guest lecturer at Stanford. Nvidia VC Alliance Partner.
Early stage75 investments 📍 United States
75
investments

Frequently asked questions about Pharmaceutical investors in United States

How many Pharmaceutical early-stage investors are there in United States?
Gritt tracks 849 Pharmaceutical early-stage investors in United States, of which 539 (63%) have a direct email address available.
How can I contact Pharmaceutical investors in United States?
Gritt provides direct email addresses for 63% of investors in this list. Once you have an account, you can export the list or use Gritt AI outreach to draft personalised emails that you review and approve, then send from your Gmail.
Are these investors actively investing in United States startups?
Yes — Gritt ranks investors by their investment activity. The investors at the top of this list have made the most investments in Pharmaceutical companies and are most likely to be actively seeking new deals.
Can I filter by investment stage or industry?
Yes — use the filters on the left to narrow by investment stage (early, mid, late) or industry. You can also filter by last active date to focus on investors who have made deals recently.
Can I export this list of Pharmaceutical investors in United States?
Yes — paid Gritt accounts can export any filtered investor list as a CSV, including names, email addresses, LinkedIn profiles and investment counts.

Contact all 849 Pharmaceutical early-stage investors

Gritt drafts a personalised AI email for each — written from your pitch; you approve each one, then it sends from your Gmail.

Start free — contact these investors
Joined by 10,600+ startups · no credit card required